594 related articles for article (PubMed ID: 21992606)
1. Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.
Saleh S; Wightman F; Ramanayake S; Alexander M; Kumar N; Khoury G; Pereira C; Purcell D; Cameron PU; Lewin SR
Retrovirology; 2011 Oct; 8():80. PubMed ID: 21992606
[TBL] [Abstract][Full Text] [Related]
2. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.
Saleh S; Lu HK; Evans V; Harisson D; Zhou J; Jaworowski A; Sallmann G; Cheong KY; Mota TM; Tennakoon S; Angelovich TA; Anderson J; Harman A; Cunningham A; Gray L; Churchill M; Mak J; Drummer H; Vatakis DN; Lewin SR; Cameron PU
Retrovirology; 2016 Jul; 13(1):49. PubMed ID: 27459960
[TBL] [Abstract][Full Text] [Related]
3. Limitations of dual-fluorescent HIV reporter viruses in a model of pre-activation latency.
Kim Y; Cameron PU; Lewin SR; Anderson JL
J Int AIDS Soc; 2019 Dec; 22(12):e25425. PubMed ID: 31855322
[TBL] [Abstract][Full Text] [Related]
4. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
5. Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.
Anderson JL; Mota TM; Evans VA; Kumar N; Rezaei SD; Cheong K; Solomon A; Wightman F; Cameron PU; Lewin SR
PLoS One; 2016; 11(7):e0158778. PubMed ID: 27383184
[TBL] [Abstract][Full Text] [Related]
6. CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency.
Saleh S; Solomon A; Wightman F; Xhilaga M; Cameron PU; Lewin SR
Blood; 2007 Dec; 110(13):4161-4. PubMed ID: 17881634
[TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.
Lucera MB; Tilton CA; Mao H; Dobrowolski C; Tabler CO; Haqqani AA; Karn J; Tilton JC
J Virol; 2014 Sep; 88(18):10803-12. PubMed ID: 25008921
[TBL] [Abstract][Full Text] [Related]
8. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
Hermankova M; Siliciano JD; Zhou Y; Monie D; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
J Virol; 2003 Jul; 77(13):7383-92. PubMed ID: 12805437
[TBL] [Abstract][Full Text] [Related]
9. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
11. Proteomic Profiling of a Primary CD4
Saha JM; Liu H; Hu PW; Nikolai BC; Wu H; Miao H; Rice AP
AIDS Res Hum Retroviruses; 2018 Jan; 34(1):103-110. PubMed ID: 29084447
[TBL] [Abstract][Full Text] [Related]
12. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.
Cameron PU; Saleh S; Sallmann G; Solomon A; Wightman F; Evans VA; Boucher G; Haddad EK; Sekaly RP; Harman AN; Anderson JL; Jones KL; Mak J; Cunningham AL; Jaworowski A; Lewin SR
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16934-9. PubMed ID: 20837531
[TBL] [Abstract][Full Text] [Related]
13. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
14. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
15. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.
Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990
[TBL] [Abstract][Full Text] [Related]
16. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
[TBL] [Abstract][Full Text] [Related]
17. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
18. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.
Jung U; Takahashi M; Rossi JJ; Burnett JC
Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
Banga R; Procopio FA; Cavassini M; Perreau M
J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
[TBL] [Abstract][Full Text] [Related]
20. Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency.
Pace MJ; Graf EH; Agosto LM; Mexas AM; Male F; Brady T; Bushman FD; O'Doherty U
PLoS Pathog; 2012; 8(7):e1002818. PubMed ID: 22911005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
